Does our current understanding of the pathogenesis of CSU provide hope of a cure for this challenging disease? Find out what Dr Riccardo Asero has to say as he joins our host to discuss some of the most fundamental questions in the field of urticariology.

Does our current understanding of the pathogenesis of CSU provide hope of a cure for this challenging disease? Find out what Dr Riccardo Asero has to say as he joins our host to discuss some of the most fundamental questions in the field of urticariology.

Does our current understanding of the pathogenesis of CSU provide hope of a cure for this&nbsp;challenging&nbsp;disease?&nbsp;Find out what Dr Riccardo&nbsp;Asero&nbsp;has to say as he joins our host to discuss some of the most fundamental questions in&nbsp;the field of&nbsp;urticariology.

Episode 28 - The pathogenesis of CSU: when will we have a cure?

Catch up on ’All Things Urticaria’ in this podcast series developed by Global Allergy and Asthma Excellence Network UCARE in collaboration with Medthority. Professor Marcus Maurer, Professor of Dermatology and Allergy at Charité – Universitätsmedizin Berlin, is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Medthority received educational funding from the sponsor to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated content. The opinions in this podcast are of the invited faculty, for informational purposes only, and should not be taken as medical advice. Please consult your regional guidelines for clinical practice recommendations in your area. For updates on ’All Things Urticaria’, sign up on Medthority. For more on UCARE/ACARE activities, visit the UCARE and ACARE websites, UCARE 4U, UDAY, CRUSE Control App, and CURE Registry.

Episodes 1 – 61: This content has been developed independently of the sponsor, Novartis Pharma AG. 
Episode 31 and 33: This content has been in collaboration with J. Uriach y Compañía S.A.

Science

Catch up on ’All Things Urticaria’ in this podcast series developed by Global Allergy and Asthma Excellence Network UCARE in collaboration with Medthority. Professor Marcus Maurer, Professor of Dermatology and Allergy at Charité – Universitätsmedizin Berlin, is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Medthority received educational funding from the sponsor to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated content. The opinions in this podcast are of the invited faculty, for informational purposes only, and should not be taken as medical advice. Please consult your regional guidelines for clinical practice recommendations in your area. For updates on ’All Things Urticaria’, sign up on Medthority. For more on UCARE/ACARE activities, visit the UCARE and ACARE websites, UCARE 4U, UDAY, CRUSE Control App, and CURE Registry. Episodes 1 – 61: This content has been developed independently of the sponsor, Novartis Pharma AG. Episode 31 and 33: This content has been in collaboration with J. Uriach y Compañía S.A.

Share Episode 28 - The pathogenesis of CSU: when will we have a cure?

Sign up to save your podcasts

Episode 28 - The pathogenesis of CSU: when will we have a cure?

Episode 28 - The pathogenesis of CSU: when will we have a cure?

More shows like All Things Urticaria

Dr. Ruscio Radio, DC: Health, Nutrition and Functional Healthcare

White Coat, Black Art

Pod Save America

The Daily

Les grands dossiers de l'Histoire par Franck Ferrand

Front Burner

The Healthy Skin Show

L'œil de Philippe Caverivière

Entrez dans l'Histoire